Turan Caner, Kovács Emőke Henrietta, Szabó László, Atakan Işıl, Dembrovszky Fanni, Ocskay Klementina, Váncsa Szilárd, Hegyi Péter, Zubek László, Molnár Zsolt
Centre for Translational Medicine, Semmelweis University, 1085 Budapest, Hungary.
Department of Anesthesiology and Intensive Therapy, Semmelweis University, 1085 Budapest, Hungary.
J Clin Med. 2024 Apr 3;13(7):2097. doi: 10.3390/jcm13072097.
: Glucocorticoids may grant a protective effect against postoperative complications. The evidence on their efficacy, however, has been inconclusive thus far. We investigated the effects of preoperatively administered glucocorticoids on the overall postoperative complication rate, and on liver function recovery in patients undergoing major liver surgery. We performed a systematic literature search on PubMed, Embase, and CENTRAL in October 2021, and repeated the search in April 2023. Pre-study protocol was registered on PROSPERO (ID: CRD42021284559). Studies investigating patients undergoing liver resections or transplantation who were administered glucocorticoids preoperatively and reported postoperative complications were eligible. Meta-analyses were performed using META and DMETAR packages in R with a random effects model. Risk of bias was assessed using RoB2. The selection yielded 11 eligible randomized controlled trials (RCTs) with 964 patients. Data from nine RCTs ( = 837) revealed a tendency toward a lower overall complication rate with glucocorticoid administration (odds ratio: 0.71; 95% confidence interval: 0.38-1.31, = 0.23), but it was not statistically significant. Data pooled from seven RCTs showed a significant reduction in wound infections with glucocorticoid administration [odds ratio: 0.64; 95% confidence interval: 0.45-0.92 = 0.02]. Due to limited data availability, meta-analysis of liver function recovery parameters was not possible. : The preoperative administration of glucocorticoids did not significantly reduce the overall postoperative complication rate. Future clinical trials should investigate homogenous patient populations with a specific focus on postoperative liver recovery.
糖皮质激素可能对术后并发症具有保护作用。然而,迄今为止关于其疗效的证据尚无定论。我们研究了术前给予糖皮质激素对接受大肝脏手术患者的总体术后并发症发生率以及肝功能恢复的影响。我们于2021年10月在PubMed、Embase和CENTRAL上进行了系统的文献检索,并于2023年4月重复了检索。研究前方案已在PROSPERO上注册(编号:CRD42021284559)。纳入研究的对象为术前接受糖皮质激素治疗且报告了术后并发症的肝切除或肝移植患者。使用R语言中的META和DMETAR软件包采用随机效应模型进行荟萃分析。使用RoB2评估偏倚风险。筛选后得到11项符合条件的随机对照试验(RCT),共964例患者。来自9项RCT(n = 837)的数据显示,给予糖皮质激素后总体并发症发生率有降低趋势(优势比:0.71;95%置信区间:0.38 - 1.31,P = 0.23),但差异无统计学意义。汇总来自7项RCT的数据显示,给予糖皮质激素后伤口感染显著减少[优势比:0.64;95%置信区间:0.45 - 0.92,P = 0.02]。由于数据可用性有限,无法对肝功能恢复参数进行荟萃分析。结论:术前给予糖皮质激素并不能显著降低总体术后并发症发生率。未来的临床试验应针对同质患者群体进行研究,尤其关注术后肝脏恢复情况。